:?

Allison Cushman-Vokoun1, Ryan J Schmidt2,3, Matthew Charles Hiemenz4

  • 1From the Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha (Cushman-Vokoun).

概括

基因编辑疗法提供了变革的潜力,但需要仔细考虑风险和道德. 病理学家必须参与这些进步,以确保在诊断和患者护理中得到适当的实施.